Antitumor effects of camptothecin combined with conventional anticancer drugs on the cervical and uterine squamous cell carcinoma cell line SiHa

Korean Journal of Physiology and Pharmacology

Volumn 13, Issue 2, 2009, Pages 115-121

  Ha, Sang Won ^a   Kim, Yun Jeong ^a   Kim, Wonyong ^b,c   Lee, Chung Soo ^a,d  

^a Departments of Pharmacology   (South Korea)

^b Departments of Microbiology

^c Chung Ang University College of Medicine   (South Korea)

^d Chung Ang University   (South Korea)

Author keywords

Camptothecin; Cell death; Combined effect of anticancer drugs; Mitochondrial membrane permeability change; SiHa cells

Indexed keywords

CAMPTOTHECIN; CARBOPLATIN; CASPASE 3; CYTOCHROME C; DOXORUBICIN; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOMYCIN C; PACLITAXEL; PROTEIN BCL 2; PROTEIN FARNESYLTRANSFERASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MONOTHERAPY; PROTEIN SECRETION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 67649322071     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2009.13.2.115     Document Type: Article

References (37)

1. Adcennann S, Bedcmann MW, Thiel F, Bogenrieder T. Topotecan in cervical cancer. INT J Gynecol Cancer 17: 1215-1223, 2007.
2. Arbuck SG, Takinxto CH. An overview of topoisomerase I-targeting agents. Semin Hernatol 35 Suppi 4: 3-12, 1998.
3. Armstrong JS. Mitochondria: a target for cancer therapy. Br J Pharmacol 147: 239-248, 2006.
4. Berthier A, Lernaire-Ecsing 5, Prunet C, Monier S, Athias A, Bessede G, Pals de Harms ,JP, Laubriet A, Gambert P, Néel D. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ 11: 97-905, 2004.
5. Blum R, Jacob-Hirsch J, Rechavi G, Kloog Y. Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesyithiosalicylic acid promotes caspase-dependent apoptosis. Mel Cancer Ther 5: 2337 2347, 2006.
6. Brown GC. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1411: 351-369, 1999.
7. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29: 323-333, 2000.
8. Chang F, Steehnan LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R, McCubrey JA. Regulation of cell cycle progression and apoptosis by the Ras/RafJMEK/ERK pathway.Int J Oncol 22: 469-480, 2003.
9. Constantini PC, Chemyak BC, Petronilli V, Bemanli P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J Biol Chem 271: 6746-6751, 1996.
10. Crow MT, Mani K, Nam YJ, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 95: 957 970, 2004.
11. Dias N, Bailly C. Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol 70: 1- 12, 2005.
12. Faivre S, Djelloul S, Raymond E. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Semin Oncol 33: 407-420, 2006.
13. Ferreira CG, Span SW, Peters GJ, Kruyt FA, Giacume G. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460. Cancer Res 60: 7133-7141, 2000.
14. Fleury C, Mignotte B, Vayssiere JL Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84: 131-141, 2002.
15. Fu W, Luo H, Parthasarathy S, Mattson MP. Catecholamines potentiate amyloid β -peptide neurotoxicity: involvement of oxidative stress, mitochonch-ial dysfunction, and perturbed calcium homeostasis. Neurobiol Dis 5: 229-243, 1998.
16. Hail AG. The role of glutathione in the regulation of apoptosis. Fur J Clin Invest 29: 238-245, 1999.
17. Hong JS, Ko HH, Han ES, Lee CS. Inhibition of bleomycin-induced cell death in rat alveolar macrophages and human lung epithelial cells by ambroxol. Biochem Pharmacol 66: 1297 1306, 2003.
18. Huang X Kurose A, Tanaka T, Traganos F, Dai W, Darsynkiewim Z. Activation of ATM and histone H2AX phosphorylation induced by mitoxantrone but not by topotecan is prevented by the antioxidant N-acetyl-L-cysteine. Cancer Biol Ther 5: 959-964, 2006.
19. Kim B, Emi M, Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 57: 545 553, 2006.
20. Kobayashi T, Sawn H, Morikawa J, ,Jhang W, Shiku H. Bax induction activates apoptotic cascade via mitochondrial cytochrome c release and Bax overexpression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells. ,Jpn J Cancer Res 91: 1264-1268, 2000.
21. Lee CS, Kim YJ, Lee MS, Han ES, Lee SJ. 18β3-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity. Life Sci 83: 481-489, 2008.
22. Lee CS, Park SY, Ko HH, Han ES. Effect of change in cellular GSH levels on mitochondrial damage and cell viability loss due to mitomycin c in small cell lung cancer cells. Biochem Pharmacol 68: 1857-1867, 2004.
23. Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur ,J Biochem 252: 1-15, 1998.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
25. Nitiss JL, Wang JC. Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA. Mol Pharmacol 50: 1095- 1102, 1996.
26. Pirnia F, Schneider E, Betticher DC, Bonier M. Mitomycin c induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway. Cell Death Differ 9: 905-914, 2002.
27. Potter SE, Champoux JJ. The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I. Nucleic Acids Res 17: 8521-8532, 1989.
28. Pritsos CA, Briggs LA, Gustafson DL A new cellular target for mitomycin c: a case for mitochondrial DNA. Oncol Res 9: 333 337, 1997.
29. Sane AT, Cantin AM, Paquette B, Wagner JR. Ascorbate modulation of H202 and camptothecin-induced cell death in Jurkat cells. Cancer Chemother Pharmacol 54: 315- 321, 2004.
30. Shao RG, Cao X, Zhang H, Kohn KW, Weld MS, Pommier Y. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA: DNA-PK complexes. EMBO J 18: 1397 1406, 1999.
31. Timur M, Akbas SH, Osben T. The effect of Topotecan on oxidative stress in MCF-7 human breast cancer cell line. Acta Biochim Pol 52: 897-902, 2005.
32. Tsao YP, Russo A, Nyamuswa G, Silber R, Liu LF. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free 5V40 DNA replication system. Cancer Res 53: 5908-5914, 1993.
33. Van Klaveren RJ, Hoet PHM, Pepe JL, Demedts M, Nemery B. Increase in γ -glutamyltransferase by glutathione depletion in rat type II pneumocytes. Free Radic Biol Med 22: 525-534, 1997.
34. Wang P, Song JH, Song DK, Zhang J, Han C Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. Cell Signal 18: 1528 1535, 2006.
35. Wensel U, Nickel A, Kuntz 5, Daniel H. Ascorbic acid suppresses drug-induced apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Carcinogenesis 25: 703-712, 2004.
36. Xia 5, Rosen EM, Laterra J. Sensitization of glioma cells to Fas-dependent apoptosis by chemotherapy-induced oxidative stress. Cancer Res 65: 5248-5255, 2005.
37. Yang X, Zhang C, Ying M, Yang B, He Q. Antiproliferation in human EA.hy926 endothelial cells and inhibition of VEGF expression in PC-3 cells by topotecan. Pharinazie 62: 534-538, 2007.